167 related articles for article (PubMed ID: 22980637)
1. Target-based selection of flavonoids for neurodegenerative disorders.
Jones QR; Warford J; Rupasinghe HP; Robertson GS
Trends Pharmacol Sci; 2012 Nov; 33(11):602-10. PubMed ID: 22980637
[TBL] [Abstract][Full Text] [Related]
2. Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences.
de Andrade Teles RB; Diniz TC; Costa Pinto TC; de Oliveira Júnior RG; Gama E Silva M; de Lavor ÉM; Fernandes AWC; de Oliveira AP; de Almeida Ribeiro FPR; da Silva AAM; Cavalcante TCF; Quintans Júnior LJ; da Silva Almeida JRG
Oxid Med Cell Longev; 2018; 2018():7043213. PubMed ID: 29861833
[TBL] [Abstract][Full Text] [Related]
3. Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction.
Dragicevic N; Smith A; Lin X; Yuan F; Copes N; Delic V; Tan J; Cao C; Shytle RD; Bradshaw PC
J Alzheimers Dis; 2011; 26(3):507-21. PubMed ID: 21694462
[TBL] [Abstract][Full Text] [Related]
4. Protective Mechanisms of Flavonoids in Parkinson's Disease.
Magalingam KB; Radhakrishnan AK; Haleagrahara N
Oxid Med Cell Longev; 2015; 2015():314560. PubMed ID: 26576219
[TBL] [Abstract][Full Text] [Related]
5. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.
Weinreb O; Mandel S; Amit T; Youdim MB
J Nutr Biochem; 2004 Sep; 15(9):506-16. PubMed ID: 15350981
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease.
Braidy N; Behzad S; Habtemariam S; Ahmed T; Daglia M; Nabavi SM; Sobarzo-Sanchez E; Nabavi SF
CNS Neurol Disord Drug Targets; 2017; 16(4):387-397. PubMed ID: 28474543
[TBL] [Abstract][Full Text] [Related]
7. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease.
Nakajima A; Ohizumi Y
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812
[TBL] [Abstract][Full Text] [Related]
8. Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.
Koutsilieri E; Riederer P
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S329-31. PubMed ID: 18267259
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease.
Choi DY; Lee YJ; Hong JT; Lee HJ
Brain Res Bull; 2012 Feb; 87(2-3):144-53. PubMed ID: 22155297
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents.
Darvesh AS; Carroll RT; Bishayee A; Geldenhuys WJ; Van der Schyf CJ
Expert Rev Neurother; 2010 May; 10(5):729-45. PubMed ID: 20420493
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Effects of Fisetin in Alzheimer's and Parkinson's Diseases: From Chemistry to Medicine.
Nabavi SF; Braidy N; Habtemariam S; Sureda A; Manayi A; Nabavi SM
Curr Top Med Chem; 2016; 16(17):1910-5. PubMed ID: 26845554
[TBL] [Abstract][Full Text] [Related]
12. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
Maher P
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
[TBL] [Abstract][Full Text] [Related]
13. Prevention of oxidative injury by flavonoids from stems and leaves of Scutellaria baicalensis Georgi in PC12 cells.
Shang YZ; Qin BW; Cheng JJ; Miao H
Phytother Res; 2006 Jan; 20(1):53-7. PubMed ID: 16397922
[TBL] [Abstract][Full Text] [Related]
14. Anti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging.
Martínez-Coria H; Arrieta-Cruz I; Gutiérrez-Juárez R; López-Valdés HE
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901731
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
16. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
Rahul ; Siddique YH
CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
[TBL] [Abstract][Full Text] [Related]
17. Can we prevent Parkinson's and Alzheimer's disease?
Kedar NP
J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787
[TBL] [Abstract][Full Text] [Related]
18. Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases.
Mandel SA; Amit T; Weinreb O; Youdim MB
J Alzheimers Dis; 2011; 25(2):187-208. PubMed ID: 21368374
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of flavonoids in the management of obesity-induced Alzheimer's disease: an overview of preclinical and clinical studies.
Kothawade SM; Buttar HS; Tuli HS; Kaur G
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2813-2830. PubMed ID: 37231172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
